4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-23-010165
Options or other derivatives
- Chief Financial Officer acquired 187,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Delfini Lisa Chief Financial Officer | 2023-02-16 | Grant or award · Stock Option (right to buy) | +187,500 | 187,500 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…